| 07/17/2026 3:05 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/16/2026 7:06 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/18/2026 3:06 PM | enGene (1980845) Filer | Form 8-K/A | |
| 06/17/2026 4:35 PM | enGene (1980845) Issuer Zoth Lota S. (1278219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:38 PM | enGene (1980845) Issuer Heffernan Michael Thomas (1448914) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:39 PM | enGene (1980845) Issuer HASTINGS PAUL J (1309702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:40 PM | enGene (1980845) Issuer Grossman William (1730229) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:41 PM | enGene (1980845) Issuer Glickman Richard M (1352637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:43 PM | BRUNK GERALD A (1380226) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:44 PM | Astley-Sparke Philip (1376491) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 4:37 PM | enGene (1980845) Issuer Joustra Wouter (1897813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ENGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/15/2026 8:14 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 8:16 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/10/2026 3:09 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 12:12 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 9:30 AM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 8:23 PM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 05/08/2026 3:06 PM | enGene (1980845) Filer | Form DEF 14A | |
| 05/07/2026 6:11 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 9:59 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 04/09/2026 3:02 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 11:20 AM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:25 AM | enGene (1980845) Filer | Form 424B5 | |
| 03/09/2026 6:09 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/09/2026 6:15 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 6:04 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | enGene (1980845) Filer | Form EFFECT | |
| 02/19/2026 3:25 PM | enGene (1980845) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/17/2026 5:09 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 2:00 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 02/17/2026 11:46 AM | enGene (1980845) Subject Kynam Capital Management, LP (1907884) Filed by | Form SCHEDULE 13G/A | |
| 01/27/2026 1:18 PM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 6:38 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:11 PM | enGene (1980845) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:04 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:12 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 6:01 AM | enGene (1980845) Filer | Form 424B5 | |
| 11/12/2025 5:16 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 6:36 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:44 PM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/11/2025 3:08 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad) We’ve found The Next Elon Musk… and what we believe to be the next Tesla.
It’s already racked up $26 billion in government contracts.
Peter Thiel just bet $1 Billion on it. 👉 Unlock the ticker now and get it completely free. |
| 09/11/2025 3:11 PM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/03/2025 6:56 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |